AlphaYouNG
Insider selling
Neil Gregory Almstead sold $222K of Ptc Therapeutics, Inc. (PTCT) stock
Neil Gregory Almstead, Chief Technical Ops Officer of Ptc Therapeutics, Inc. (PTCT), sold 2,464 shares of PTCT stock worth $222K, per an SEC Form 4 filed Jul 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 4 days before it was made public.
PTCT has moved -27.1% since the trade date, from $89.55 to $65.26 (Sep 21, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 13, 2026
- Filing delay
- 4 days
- Price since
- -27.1%
- Role
- Chief Technical Ops Officer
- Source
- SEC Form 4
More PTCT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.